LCS
TEVA icon

Levin Capital Strategies’s Teva Pharmaceuticals TEVA Stock Holding History

Levin Capital Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-79,650
Closed -$4.96M – 399
2015
Q1 		$4.96M Hold
79,650
– – 0.07% 128
2014
Q4 		$4.58M Sell
79,650
-35,790
-31% -$1.99M 0.07% 134
2014
Q3 		$6.21M Sell
115,440
-14,965
-11% -$793K 0.09% 120
2014
Q2 		$6.84M Sell
130,405
-24,035
-16% -$1.23M 0.11% 125
2014
Q1 		$8.16M Hold
154,440
– – 0.14% 108
2013
Q4 		$6.19M Hold
154,440
– – 0.1% 116
2013
Q3 		$5.83M Sell
154,440
-42,100
-21% -$1.64M 0.1% 119
2013
Q2 		$7.7M Buy
+196,540
New +$7.65M 0.14% 102

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Levin Capital Strategies's TEVA Position: Q2 2015 in Review

Levin Capital Strategies sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 79,650 shares — an estimated $4.96M sold.

Levin Capital Strategies first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $8.16M in Q1 2014. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Levin Capital Strategies reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Levin Capital Strategies sold 79,650 Teva Pharmaceuticals shares in Q2 2015, an estimated $4.96M.
  • Levin Capital Strategies first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Levin Capital Strategies's Teva Pharmaceuticals position peaked at $8.16M in Q1 2014.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Levin Capital Strategies's 13F filing for Q2 2015, filed 12 Aug 2015.